Natural Cytotoxicity of NC‐2⁺ Cells Against the Growth and Metastasis of WEHI‐164 Fibrosarcoma

Abstract

We have previously reported a new receptor (NC‐2) for natural cytotoxicity (NC) on murine leucocytes, identified by monoclonal antibody D9 (mAb D9). Pretreatment of mouse spleen cells with different concentrations of mAb D9 in vitro blocked NC against WEHI‐164, whereas natural killing (NK) activity against YAC‐1 was unaffected. This paper reports the immune surveillance against the growth of WEHI‐164 tumour cells in mice by NC‐2+ Cells. The kinetics of in vivo reduction in NC activity were investigated by treating BALB/c and (CBA × C57BL/6) F1 mice with a single injection of 40 μg of mAb D9 and monitoring splenic NC activity by 51Cr‐release assay at intervals from 24 h to 3 weeks. Control mice were injected with OKT8 irrelevant antibody. Results showed a significant (P < 0.05) reduction in splenic NC activity within 24 h which persisted for up to 1 week. Similar results were also obtained when (CBA × C57BL/6) F1 mice were employed (P < 0.001). In vivo tumour studies were undertaken to investigate the role of NC‐2+ cells in surveillance against tumour growth and metastasis of the WEHI‐164 fibrosarcoma. When syngeneic BALB/c mice were injected with 40 μg of mAb D9 and then challenged with 5 × 105 WEHI‐164 cells, results showed significantly increased growth rate of the transplanted WEHI‐164 fibrosarcoma and tumour nodules in the lungs of animals, when compared to control mice with normal NC activity. Our data support an innate surveillance in metastasis and growth of WEHI‐164 fibrosarcoma in mice.

The Toll-Like Receptor 3 Agonist Polyriboinosinic Polyribocytidylic Acid Increases the Numbers of NK Cells with Distinct Phenotype in the Liver of B6 Mice

“…This suggestion is in line with earlier research that demonstrated how the poly(I:C) treatment initiated accumulation of active NK cells in the liver through the inducing of these cells to migrate from the spleen through to the liver [41]. These findings shed a light on the antitumour impact of poly(I:C) on metastatic tumours given that such tumours secrete interferon as we have previously shown [18,21,26,39] and that NK cells have a part in immune surveillance against cancerous cells [45] and that they are able to eradicate cancers from the liver [8,33]. These findings also contribute to future research in this area in further examining the impact of the poly(I:C) treatment against liver tumours when taken systemically or via hepatic portal injection.…”

Nutritional Genomics - An Overview of CRISPR/Cas9 Genome Editing System on Nutraceuticals

“…Globally, cancer is the leading cause of death, with almost 10 million deaths in 2020 [38]. Lycopene, a carotenoid, is an antioxidant and a singlet oxygen quencher that has been found to be protective against cancer in the prostate, testes, and skin, where it is concentrated; it also decreases oxidative stress and DNA damage [25,39,40]. Antioxidant nutraceuticals are primarily implicated in cancer, for example, β-carotene.…”

Microwave- and Ultrasound-Assisted Extraction of Cucurbita pepo Seeds: A Comparison Study of Antioxidant Activity, Phenolic Profile, and In-Vitro Cells Effects

“…In the past years, nutraceuticals received particular attention from consumers due to their potential to improve health, delay the aging process, increase life expectancy, prevent chronic diseases, and even support the structure or function of the body [3]. Different studies reported that nutraceuticals, such as ginseng, green tea, sumac, folic acid and cod liver oil, present promising results in different pathological complications, such as atherosclerosis [4,5], cardiovascular diseases [6,7], diabetes [8], cancer [9,10] and neurological disorders [11]. Furthermore, recently published reports demonstrated the positive effects of nutraceutical plants as Zizyphus jujube [12] or Lavandula officinalis [13] on the Alzheimer's disease, learning and memory.…”